Related Experiment Video
Updated: May 14, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress
Parisa Younessi1, Ali Yoonessi
1Centre for Complementary Medicine Research, University of Western Sydney, Campbelltown Campus, Sydney, Australia. ; Faculty of Applied Science, University of Canberra, Canberra, Australia.
Abstract:
Glycation is a protein modification, which results in a change in a protein structure. Glycation is believed to be the etiology of various age-related diseases such as diabetes mellitus and Alzheimer's disease (AD). Activation of microglia and resident macrophages in the brain by glycated proteins with subsequent oxidative stress and cytokine release may be an important factor in the progression of AD. It is also suggested that interaction between an advanced glycation end product (AGE) and its receptor (RAGE) results in glial activation as well as cytokine release and reactive oxygen species release. The use of antioxidants, receptor mediated compounds and reactive oxygen species scavenging enzyme produce an opportunity to intervene with AGE-RAGE signaling pathway, and thereby to slow down the progression of aging-related diseases.
Related Concept Videos
Diabetic Neuropathy
Inflammation
Proteoglycans
Type II Diabetes II: Pathophysiology
Chronic Inflammation: Introduction
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
